TrialVaccine2019

A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.

Michele Andrasik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.